Masaru Kurita

Title: The Innovations of Masaru Kurita

Introduction

Masaru Kurita is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in antibiotic development. With a total of 4 patents to his name, Kurita's work has had a lasting impact on medical science.

Latest Patents

Among his latest patents is the invention of 7-(.beta.-Aminoacylamino)-3-substituted-3-cephem-4-carboxylic acid. This patent includes derivatives of the formula where R.sub.1 can be hydrogen, lower alkyl, lower alkenyl, aryl, or a heterocyclic group. Another significant patent is the process for the purification of FR-1923 substance. This process involves the purification of the FR-1923 antibiotic substance by treatment with a macroporous non-ionic adsorption resin, such as styrene-divinyl benzene copolymer or acrylic ester polymer.

Career Highlights

Masaru Kurita is currently associated with Fujisawa Pharmaceutical Company, Ltd. His work at this esteemed organization has allowed him to focus on innovative solutions in the pharmaceutical industry. His contributions have been instrumental in advancing antibiotic treatments.

Collaborations

Throughout his career, Kurita has collaborated with notable colleagues, including Osamu Nishiwaki and Kazuyoshi Jomon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Masaru Kurita's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective antibiotic treatments.